1Y Close · As of Aug 26, 2026
SAMIL PHARMACEUTICAL operates in the Pharmaceuticals sector.
Legal name: SAMIL PHARMACEUTICAL CO.,LTD
In fiscal year 2025, SAMIL PHARMACEUTICAL (000520) reported revenue of 210.3 billion KRW, down 4.3% from 219.7 billion KRW a year earlier.
Operating profit was -22.2 billion KRW and net income was -34.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 136.9 billion KRW, with a P/B of 1.03.
These figures can be verified in the DART filing (receipt no. 20260318001625).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 210.3B | -22.2B | -34.7B |
| 2024 | 219.7B | 113M | -5.6B |
| 2023 | 196.3B | 6.5B | 1.7B |
| 2022 | 179.7B | 4.0B | -28M |
| 2021 | 134.2B | 400M | -5.3B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |